Eduardo Rodriguez Almaraz

Title(s)	SENIOR CRC SUPERVISOR, Neurological Surgery
School	School of Medicine
Address	400 Parnassus Avenue, #A808 San Francisco CA 94117
Phone	415-514-5529 ext. 45529
ORCID	0000-0003-0978-1117
vCard	Download vCard

Other Positions


Title(s)	UCSF Weill Institute for Neurosciences

Biography

Education and Training

National Polytechnic Institute, Mexico	MD	11/2012	Medicine
University of California, San Francisco, San Francisco	MAS	06/2019	Clinical Research
University of California, San Francisco, San Francisco	PhD	ongoing	Epidemiology and Translational Science (DE: Computational Precision Health)

Overview

Interests

Neuro Oncology, Oncology Clinical Trials, Precision Medicine, Machine Learning, SMART studies, Quality of Life, Cannabis and glioma, AI in Cancer, Cancer genetics

Research

Research Activities and Funding

Identification of actionable mutations in IDH-mutant gliomas using next generation sequencing (UCSF 500)
UCSF - Molecular oncology program Aug 1, 2022 - Aug 1, 2023
Role: Principal investigator

Sullivan Grant Aug 31, 2020 - Jul 31, 2022

Impact of Cannabis and synthetic cannabinoid use on quality of life of patients with central nervous system tumors (ICANCNS-QoL)
Jun 3, 2018
Role: Co-Investigator

ORNG Applications

Collaboration Interests

Featured Videos

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis). Curr Treat Options Oncol. 2023 Jan 12. Rodriguez-Almaraz JE, Butowski N. PMID: 36633803.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Neuro-Oncology. Retroelement expression in glioma tumors exhibits subtype specific patterns. 2022; 24(Suppl_2):ii50. JE Rodriguez Almaraz, G Guerra, G Wendt, S Chang, S S Francis. View Publication.
Neuro-Oncology. BIOM-07. Quantitative MGMT Promoter Methylation Index indicates a non-linear prognostic effect in glioblastoma, suggesting that use of optimal cutoff points may be clinically disadvantageous. 2021; 23(suppl_6):vi11. Gibson, D., Ravi, A., Rodriguez Almaraz E. , Chang, S., Oberheim-Bush, N. A., Taylor, J., Clarke, J., Solomon, D., Scheffler, A., Witte, J., Lambing, H., Berger, M., Okada, H., Chehab, F., & Butowski, N. View Publication.
Journal of Clinical Oncology. Pilot trial treating recurrent GBM patients with precision medicine regimens. 2021; 39(15_suppl):2045-2045. Jennifer Leigh Clarke, David Solomon, Nancy Ann Oberheim Bush, Jennifer A. Grabowsky, Cassie Kline, Deanna L. Kroetz, Jennie Webster Taylor, Javier Villanueva-Meyer, Annette Molinaro, David Gibson, Meghan Tedesco, Jane E Rabbitt, Eduardo Rodriguez Almaraz, Jessica Schulte, Robin Arthur Buerki, Shawn L. Hervey-Jumper, Manish K. Aghi, Mitchel S. Berger, Edward Chang, and Susan Marina Chang. View Publication.
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors. A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors. 2020; (7). Eduardo Rodriguez Almaraz, MD, MAS, Susan Chang, MD, Jennifer Clarke, MD, MPH, Nancy Ann Oberheim-Bush, MD, PhD, Jennie Taylor, MD, Robin Buerki, MD, Mitchell Berger, MD, Lydia Zablotska, MD, PhD, Iryna Lobach, PhD, Nicholas Butowski, MD. View Publication.
PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma. 2019; 21(Supp_6):vi22-vi23. Jennie Taylor, Annette Molinaro, Eduardo Rodriguez Almaraz, Ciara Downey, Joanna Phillips, Nancy Ann Oberheim-Bush, Nicholas Butowski, Susan Chang, Mitchel Berger, Michael Prados, Daphne Haas-Kogan, Jennifer Clarke. View Publication.
Impact of cannabis use on quality of life in patients with central nervous system tumors. 2019; 21(Supp_3):iii37. J E Rodriguez Almaraz, S M Chang, N A E Oberheim-Bush, J R Clarke, J W Taylor, R A Buerki, M S Berger, N A Butowski. View Publication.
Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity. Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity. 2014; 3(81). Morin-Zaragoza R, Rodriguez-Choreno JD, Morales-Suarez MO, Rodriguez Almaraz JE. . View Publication.
Mexican Contributions to the study of Obesity. Pharmacology chapter. 2014. Leija, Gerardo. View Publication.
Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats. 2013. Lopez-Canales JS, Lozano-Cuenca J, Morin-Zaragoza R, Rodriguez Almaraz JE. . View Publication.